Estadístiques de Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study

Visites totals

views
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study 4

Visites totals per mes

views
April 2025 0
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0

Visites al fitxer

views
Cicin_bc_epac.pdf 157